Eli Lilly and Co LLY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 7:10 PM EDT

725.28

-6.92 (-0.95%)

Volume

183,155

732.20

-13.49 (-1.81%)

Volume

1,942,535

52 week range

370.68 - 800.78

Open752.64
Day High752.64
Day Low728.78
Prev Close745.69
52 Week High800.78
52 Week High Date03/04/24
52 Week Low370.68
52 Week Low Date04/26/23

Key Stats

Market Cap696.151B
Shares Out950.77M
10 Day Average Volume2.34M
Dividend5.20
Dividend Yield0.71%
Beta0.38
YTD % Change25.61

KEY STATS

Open752.64
Day High752.64
Day Low728.78
Prev Close745.69
52 Week High800.78
52 Week High Date03/04/24
52 Week Low370.68
52 Week Low Date04/26/23
Market Cap696.151B
Shares Out950.77M
10 Day Average Volume2.34M
Dividend5.20
Dividend Yield0.71%
Beta0.38
YTD % Change25.61

RATIOS/PROFITABILITY

EPS (TTM)5.80
P/E (TTM)126.22
Fwd P/E (NTM)58.45
EBITDA (TTM)11.853B
ROE (TTM)48.93%
Revenue (TTM)34.124B
Gross Margin (TTM)79.25%
Net Margin (TTM)15.36%
Debt To Equity (MRQ)234.18%

EVENTS

Earnings Date04/30/2024(est)
Ex Div Date11/14/2023
Div Amount1.13
Split Date-
Split Factor-

Latest On Eli Lilly and Co

A rapid-fire update on our 33 stocks including the tech giants reporting this week4 Hours AgoCNBC.com
April Monthly Meeting: Jim Cramer shares his outlook as earnings season heats up6 Hours AgoCNBC.com
Why this is perfect time to buy health-care stocks, one financial advisor saysApril 23, 2024CNBC.com
Most weight loss drug patients are spending less on restaurants, takeout: surveyApril 20, 2024CNBC.com
These are the 10 most overvalued stocks in the S&P 500April 18, 2024CNBC.com

Content From Our Affiliates

Eli Lilly (NYSE:LLY) Notches Up on New Manufacturing PlansApril 22, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Eli Lilly & Co (LLY)April 22, 2024TipRanks
Influencers are talking up weight loss drugs, but omit side effects, WSJ saysApril 19, 2024TipRanks
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), TG Therapeutics (TGTX)April 18, 2024TipRanks
UBS remains bullish on Inspire Medical after Lilly’s OSA resultsApril 18, 2024TipRanks

Profile

Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz....

David Ricks

Chairman of the Board, President, Chief Executive Officer

Anat Ashkenazi

Chief Financial Officer, Executive Vice President

Diogo Rau

Executive Vice President, Chief Information and Digital Officer

Patrik Jonsson

Executive Vice President, President of Lilly Diabetes and Obesity and President of Lilly USA

Alonzo Weems

Executive Vice President - Enterprise Risk Management, Chief Ethics and Compliance Officer

Address

Lilly Corporate Ctr

Drop Code 1094, Lilly Corporate Ctr

Indianapolis, IN

46285-0001

United States

https://www.lilly.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	127.00	+0.12	+0.09%
ABBV AbbVie Inc	167.80	-1.74	-1.03%
JNJ Johnson & Johnson	148.53	-1.03	-0.69%
AZN AstraZeneca PLC	71.20	+0.35	+0.49%
NVS Novartis AG	98.35	+1.07	+1.10%